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influence of dose resolution (re-sempling of the simulated 
dose distribution to the detector resolution) on gamma 
result. Clinical relevance of such MLC errors should be also 
investigated. 
 
EP-1600  
VMAT lung SBRT: 3D evaluation in pretreatment patient QA 
and in vivo dose verification 
E. Villaggi
1AUSL Piacenza, Fisica Sanitaria, Piacenza, Italy 
1 
 
Purpose or Objective: SBRT requires patient specific-QA 
with high spatial resolution, stability and dynamic range. 
EPID dosimetry has been proofed to be efficient to give 
accurate results for both conventional and special 
treatments. In this work, a commercial QA software is used 
for a lung SBRT clinical case to obtain 3D dosimetry from 
fluences measured by EPID gantry angle-resolved data 
acquisition. The purpose is obtain information on actual 
delivered dose to the tumor volume and surrounding critical 
structures in terms of clinical dosimetric parameters which 
are meaningful for both physicians and physicists. 
 
Material and Methods: VMAT SBRT lung treatment is planned 
by Varian Eclipse treatment planning system using ACUROS 
algorithm. Treatment is delivered using a Varian2100CD 
linear accelerator’s 6 MV x-ray beam. Fluences are acquired 
on a Varian aSi1000 EPID. Dosimetry Check (Math Resolutions 
LLC) is a commercial QA software performing 3D treatment 
plan verification: the necessary measurements for the exit 
image kernel for SBRT includes EPID images of various field 
sizes ( minimum field size: 1x1 cmxcm). Fluence maps 
acquired on the EPID during pre-treatment QA and patient 
treatment are separately applied to the patient’s CT. 
Agreement between planned and delivered dose distributions 
for patient-specific SBRT quality assurance is assessed for a 
lung case utilizing the gamma index method ad dose volume 
histogram (DVH)-base metrics. The stereotactic approach 
requires a tight margin: the distance to agreement criterion 
is set to 1mm. The dose difference is set to 3% if a 
homogeneous phantom is used and 5% for calculations on a 
heterogeneous CT set. 
 
Results: Results include 3D gamma evaluation and dose 
volume histogram (DVH). Volumetric, planar, and point dose 
comparison between measured and computed dose 
distribution agreed favorably indicating the validity of 
technique used for VMAT SBRT QA. Gamma pass rate in axial, 
coronal and sagittal plane through the isocenter is 
respectively 93,4%, 86,3% and 95,1% for pretreatment QA; 
92,8%, 82,6% and 76% for in vivo QA. 3D values are 89,4% and 
90%. Significant clinical structure values from DVH are shown 
in Table 1. 
 
 
 
Conclusion: An efficient procedure of verifying VMAT lung 
SBRT plans with high accuracy has been obtained. Results 
from a clinical case are presented in terms of doses to the 
anatomical structures and in terms of gamma evaluation. 
Dosimetry Check system employes a pencil beam algorithm in 
order to calculate dose from fluence measurements taken 
with the EPID. It can be assumed that some dose differences 
will arise from the pencil beam algorithm used in Dosimetry 
Check and the more sophisticated algorithms used in TPS. 
Differences may depend on the level of heterogeneity of the 
anatomical site. Further research is needed to assess these 
differences. 
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Purpose or Objective: The aim of this abstract was to report 
the observed differences between measured and Monte Carlo 
(MC) calculated dose distributions when using common 
incident electron energy matching techniques. 
 
Material and Methods: PDDs and profiles on a 6MV Elekta 
Precise linac were acquired in a PTW MP3 watertank with a 
semiflex chamber (0.125cm3) at 90cm SSD. A MC model of 
the linac was created in BEAMnrc. Phase Space files were 
scored at 90cm from the target at a plane perpendicular to 
the direction of the beam. The phase space files were used 
as an input into DOSXYZnrc to calculate dose in a water 
phantom (60x60x30cm2, 90cm SSD, voxel 
size=0.3x0.3x0.3cm3). The incident electron beam was set to 
have a Gaussian distribution with a FWHM in the GT and AB 
directions of 1.92 and 2.42 mm respectively. The energy 
spectrum of the incident electron beam had a FWHM of 
0.5MeV and an energy window of ±0.6MeV. The mean energy 
of the incident electron beam was determined in two ways:  
Method 1:  
The mean energy of the electron beam was varied until the 
calculated CAX PDD matched the measured for a 10x10cm2 
photon field (between 5-25 cm). 40x40cm2 dose profiles 
(90cm SSD, 10cm deep) were subsequently calculated and 
compared to measurement. Method 2:  
The mean energy of the electron beam was varied until the 
calculated 40x40cm2 dose profiles matched the measured 
profiles to within 0.5% (within 80% field width). A 10x10cm2 
CAX PDD (90cm SSD) was subsequently calculated and 
compared to measurement. 
 
Results:  
Results - 1:  
The agreement between calculated and measured 10x10cm2 
CAX PDD was best (between 5-25cm) for an incident electron 
beam mean energy of 6.65MeV. The resultant 40x40cm2 
profiles at 90cm SSD, 10cm deep, revealed a reduction in the 
dose horns of 4% in comparison to the measured profile 
(Figure 1).  
Results - 2:  
The agreement between calculated and measured 40x40cm2 
profiles at 90cm SSD, 10cm deep was best for an incident 
electron beam with a mean energy of 6.2MeV. The resultant 
CAX 10x10cm2 PDD revealed an agreement to within 1% 
(between 5-25cm) of the measured PDD. 
 
 
